United Therapeutics Corp (NASDAQ:UTHR)

106.27
Delayed Data
As of May 18
 -1.43 / -1.33%
Today’s Change
100.57
Today|||52-Week Range
152.55
-28.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line340.1M651.6M713.7M417.9M
 
 
 
 
 
Depreciation32.2M32.9M31.6M31.0M
 
 
 
 
 
Total Other Cash Flow183.4M-99.6M15.7M103.7M
 
 
 
 
 
Funds From Operations740.8M584.9M761.0M552.6M
 
 
 
 
 
Funds From/For Other Operating Expenses385.6M202.2M117.4M78.4M
 
 
 
 
 
Net Cash Flow - Operating Activities355.3M382.8M643.6M474.2M
 
 
 
 
 
 
InvestingIncrease In Investments-163.7M-117.0M-38.9M-830.6M
 
 
 
 
 
Decrease In Investments549.6M320.4M130.4M72.9M
 
 
 
 
 
Capital Expenditures-47.4M-49.8M-38.0M-86.3M
 
 
 
 
 
Fixed Asset Disposal------8.3M
 
 
Other Investing - Sources0.00350.0M0.00100.0K
 
 
 
Net Cash Flow Investing338.5M503.6M48.3M-835.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings140.0M0.00-6.8M249.3M
 
 
 
 
Long Term Debt Reduction-317.8M-133.2M-8.8M0.00
 
 
 
 
Net Proceeds Stock Sale53.5M43.3M12.0M44.0M
 
 
 
 
 
Common Preferred Redeemed-483.1M-394.5M-500.0M-250.0M
 
 
 
 
 
Common Dividends0.000.00------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing30.8M37.4M5.9M0.00
 
 
 
 
Other Uses - Financing------0.00--
Net Cash Flow - Financing-576.5M-446.9M-497.7M43.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-3.8M-5.3M-3.0M200.0K
 
 
 
 
 
 
Net Change In Cash117.2M439.4M194.2M-318.1M